<DOC>
	<DOCNO>NCT00133874</DOCNO>
	<brief_summary>The goal study determine topical SB-275833 ointment , 1 % safe effective topical sodium fusidate ointment , 2 % treatment impetigo adult child young 9 month age .</brief_summary>
	<brief_title>Topical SB-275833 Ointment , 1 % For The Treatment Of Impetigo</brief_title>
	<detailed_description>A Randomised , Observer-blind , Multicentre , Non-inferiority , Comparative , Phase III Study Safety Efficacy Topical 1 % SB-275833 Ointment , Applied Twice Daily 5 Days , versus Topical 2 % Sodium Fusidate Ointment Applied Three Times Daily 7 Days Treatment Adult Paediatric Subjects Impetigo .</detailed_description>
	<mesh_term>Skin Diseases , Infectious</mesh_term>
	<mesh_term>Impetigo</mesh_term>
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>Inclusion criterion : Must primary impetigo total lesion area 100 square centimeter less . Women could bear child must negative urine pregnancy test agree either abstain sexual intercourse use specific effective contraceptive measure . Any sign symptom systemic infection . Any serious underlying disease could imminently life threatening .</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>topical antibacterial</keyword>
	<keyword>topical antibiotic</keyword>
	<keyword>impetigo</keyword>
</DOC>